Phi X 174 Virus Reduction
- Authors
- Park Seo-Hyun and Jeon, Yong- Woo, Technical Manager
- Facility
- Korea Testing Laboratory
- Download
- Full Report
Objective
To assess the performance of the Defend 1050 in reducing phi X 174 virus a surrogate for Hepatitis B23, Hepatitis C23 and HIV2.
Methodology
- Test Method: KOUVA AS02: 2019
- Virus: Phi-X174 (ATCC 13706-B1)
- Temperature: (23 +/- 2) °C
- Humidity: (50 +/- 5) % R.H.
- Test time: 30 minutes
- Test chamber: 60m3
- Air flow: Maximum
Summary of Results
The Defend 1050 achieved a 98.8% reduction of phi X 174 virus in 30 minutes in a 60m3 chamber.
